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INTRODUCTION
Medicinal plants occur naturally and are widely used in a large 
number of countries all around the world. People use them either 
in the form of traditional preparations or as pure active forms usu‑
ally for their known therapeutic qualities and in order to avoid the 
harmful side effects of prescription medicine. One such plant is 
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ABSTRACT
Plantago major is a common plant that grows worldwide in temperate zones and is found in fields, lawns, and on the roadsides. Its leaves 
and seeds have been used in almost all parts of the world for centuries as a wound healer, analgesic, antioxidant, and antibiotic, as well as 
an immune system modulator, antiviral, antifungal, and anti‑inflammatory agent. Baicalein and aucubin are the two most biologically active 
components of P. major, and both have been shown to have antioxidant, anti‑inflammatory, and anticancer properties. Neutrophils have a 
pivotal role in wound healing and inflammation. Their principal mechanism of host defense is the killing of pathogens via the production 
of reactive oxygen species (ROS). The aim of the present study was to determine the in vitro effects of P. major extract, baicalein, and 
aucubin on human neutrophil respiratory burst activity. The cytotoxicity of the agents was assessed by lactate dehydrogenase (LDH) assays. 
A standard luminol‑dependent chemiluminescence (CL) assay was utilized to monitor the respiratory burst of the neutrophils after exposure 
to P. major extract and its two active ingredients, baicalein and aucubin. Three replicates per group were included in each of the three runs of 
the experiments and analysis of variance (ANOVA) was used for statistical analysis. P. major and baicalein were not toxic to the cells at any 
of the concentrations examined. Aucubin was toxic to the cells only at the highest concentration tested (P = 0.0081). However, genistein was 
toxic to the cells at all of the concentrations examined except for the lowest concentration of 16.9 µg/ml (P = 0.985). P. major (−0.10 ± 0.11), 
aucubin (0.06 ± 0.16), baicalein (−0.10 ± 0.11), and genistein (−0.18 ± 0.07) all significantly (P < 0.0001) inhibited ROS production from 
the neutrophils. P. major extract inhibited neutrophil ROS production, as did aucubin and baicalein. Therefore, these components should be 
investigated further with relation to the regulation of destructive ROS production in conditions such as periodontal disease.
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Plantago major, also known as Ribwort, which is readily avail‑
able in many parts of the world; its leaves and seeds have been 
used for centuries as an anti‑inflammatory, analgesic, antioxidant, 
anti‑infective, immune‑modulating, anti‑ulcerogenic, anti‑fungal, 
and anti‑cancer agent, as well as for wound healing purposes.[1‑6]
The properties of P. major are modulated by the different 
components of the plant. These include carbohydrates, lipids, 
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alkaloids, caffeic acid derivatives, flavonoids, irioid glycosides, 
and other terpenoids. The chemical analysis of the leaves revealed 
the presence of aucubin, a glycoside, which has been reported in 
several studies to be a powerful anti‑toxin. There are also some 
other effective ingredients in this plant such as baicalein, ascorbic 
acid, apigenin, benzoic acid, chlorogenic acid, citric acid, ferulic 
acid, oleanolic acid, salicylic acid, and ursolic acid.[7]
Neutrophil granulocytes (also termed polymorphonuclear leuko‑
cytes),[8] which are generally referred to as neutrophils, are the most 
abundant type of white blood cells (40‑70%) in humans and form a 
crucial part of the host defense system. Neutrophils are short‑lived 
cells normally found in the blood stream after their release from the 
bone marrow. However, during the acute phase of inflammation, 
particularly as a result of bacterial infection, bone marrow output 
of neutrophils increases and they migrate toward the site of inflam‑
mation to confront the pathogens. Neutrophils react within an hour 
of tissue injury and are the hallmark of acute inflammation.[9] They 
phagocytize microorganisms, internalizing and killing as many as 
possible. Each phagocytic event will result in the formation of a 
phagosome into which reactive oxygen species (ROS) are secreted 
for microbial destruction. The consumption of oxygen during the 
generation of ROS has been termed the “respiratory burst.” This 
process plays a significant role in the inflammation‑induced tissue 
damage and the antioxidant defense mechanisms associated with 
periodontal diseases and other inflammatory oral conditions.[9]
This study investigated the in vitro effects of P. major extract, 
baicalein, and aucubin on the respiratory burst activity of human 
neutrophils. The aim was to explore the potential medicinal prop‑
erties of P. major in an effort to promote the use of this readily 
accessible resource for the benefit of oral and general health.
MATERIALS AND METHODS
The study was approved by the Institutional Review 
Board (IRB) of Indiana University Purdue University under 
the application for research not subject to FDA or common rule 
definitions of human subjects research, prior to commencement 
of the study (e.g., IRB study number: 0309‑56). No human sub‑
jects were recruited specifically for this study. The buffy coat 
samples were purchased from Indiana Regional Blood Center 
and were de‑identified. P. major (30×) extract was purchased 
from Washington Homeopathic Products (Berkeley Springs, WV, 
USA). Baicalein, aucubin, and genistein were purchased from 
Sigma‑Aldrich (St. Louis, MO, USA).
Neutrophil isolation
Six buffy coats, separated from healthy adult human do‑
nor blood, were purchased from the Central Indiana Regional 
Blood Center in Indianapolis, Indiana. To obtain the buffy coats, 
de‑identified healthy human donor blood was collected by the 
blood center in citrate phosphate dextrose solution anticoagulant 
bags and centrifuged at 2000 × g at 4°C for 4 min. Buffy coat lay‑
ers were then drawn off by the blood center and provided for this 
study. In the laboratory, the buffy coats were diluted in a 1:1 ratio 
with Rosewell Park Memorial Institute Medium (RPMI) (Sigma 
Chemicals, St. Louis, MO, USA) to maximize the efficiency 
of separation. The neutrophils were isolated from the buffy 
layer by the double dextran gradient method as described previ‑
ously.[10] Briefly, 3 ml aliquots of HISTOPAQUE‑1119 (Sigma 
Chemicals) were placed in test tubes and then 3 ml of HIS‑
TOPAQUE‑1077 (Sigma Chemicals) was added to each tube. 
Then, 6 ml of buffy coat/RPMI mixture was layered on the top, 
centrifuged, and washed three times with media, followed by 
centrifugation after each wash. The cells were then re‑suspended, 
stained with Trypan Blue (Sigma Chemicals) to verify viability, 
and counted to determine the number of neutrophils.
Lactate dehydrogenase cytotoxicity assays
Cellular membrane integrity was monitored by the permeabil‑
ity assay based on the release of lactate dehydrogenase (LDH) into 
the media. The Cytotoxicity Detection Kit‑PLUS (Roche Applied 
Science, Mannheim, Germany) measures the conversion of tetra‑
zolium salt to a red formazan product. The amount of formazan 
produced is proportional to the amount of LDH released into the 
culture medium as a result of cytotoxicity.
Neutrophils were added to six‑well plates (100,000 cells per 
well). After 3 h, the neutrophils were incubated at 37ºC for 2 h with 
P. major extract diluted in media, as well as with aucubin, baica‑
lein, or genistein at various concentrations. Total cell death (high 
control) was generated by the addition of 1.9 ml of serum‑free 
RPMI and 0.1 ml of lysis solution to control cells as described by 
the manufacturer. Untreated cells served as the low control and 
represented no cytotoxicity. Samples (100 µl) were transferred to 
96‑well plates. An aliquot (100 µl) of the reconstituted mix as per 
the manufacturer was added to each well. The plates were then 
incubated for 30 min at room temperature. The absorbance was 
recorded at 490 nm in a microplate reader (Titertek, Multiskan 
MCC, Flow Laboratories, McLean, VA, USA). The experiments 
were repeated six times and the mean values calculated. The 
percentage release of LDH was calculated from the treated cells 
by comparing it with the maximum release of LDH as follows:
cytotoxicity (%) = (experimental value – low control)/(high 
control – low control) × 100%.
Chemiluminescence assays
These assays were performed as per the previously established 
protocols using the Bio‑Orbit 1251 Luminometer (Bio‑Orbit, 
Turku, Finland).[10] For each of the three runs of the experi‑
ments, there were 16 reaction cuvettes. To each reaction cuvette, 
the following were added: 500 µl of neutrophil suspension of 
500,000 cells in RPMI‑1640 media, 300 µl of phosphate‑buffered 
saline (PBS), and 100 µl luminol that served as a chemilumines‑
cence (CL) probe for signal augmentation. It was dispensed at base‑
line and then after 30 min, 3% of P. major extract, 0.01 µg/ml of 
aucubin, 0.085 µg/ml of baicalein, or 16.9 µg/ml of genistein was 
added. A negative control that contained no neutrophils and a posi‑
tive control of N‑formyl‑methionyl‑leucyl‑phenylalanine (fMLP, 
10−5 M) treated neutrophil sample were included. The reaction was 
followed for 90 min and this represented the neutrophil activation 
phase. Neutrophil activation was recorded in millivoltage and the 
intervals were calculated. Data analyses were performed on the 
mean values of the triplicate experiments.
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High‑performance liquid chromatography
Twenty microliters of the P. major extract (30×) were processed 
through a high‑pressure liquid chromatography (HPLC) instrument 
equipped with a series 200 pump, a 785A tunable UV‑VIS detector, 
and a Brownlee C‑18 reverse phase column (25 cm × 4.6 mm, 5 
µm particle size), all from Perkin‑Elmer (Shelton, CT, USA). The 
chromatography was performed with a flow rate of 1 ml/min and 
with acetonitrile/water mobile phase at 210 nm.
Statistical methods
One‑sided tests were used to compare each group in the LDH 
assays with the negative control (untreated cells). CL data from 
each experimental run were divided by the positive control mean 
to standardize the data from the different experimental runs. CL 
values for each of the groups were summarized (mean, standard 
deviation, standard error, minimum and maximum). Comparisons 
between the groups for differences in CL values were performed 
using mixed‑model analysis of variance (ANOVA). The ANOVA 
included a term for group, as well as a random effect for experi‑
mental run. The analyses were performed using the ranks of the CL 
values to satisfy the distributional assumptions required for ANOVA.
RESULTS
LDH cytotoxicity assays
The cytotoxicity was examined at different concentrations 
of P. major, aucubin, baicalein, and genistein. P. major was pre‑
pared in ethanol, whereas aucubin, baicalein, and genistein were 
prepared in dimethylsulfoxide (DMSO). The alcohol and DMSO 
at the final concentrations utilized for the agents were not toxic 
to the cells (data not shown). P. major and baicalein were not 
toxic to the cells at any of the concentrations examined [Table 1]. 
Aucubin was toxic to the cells only at the highest concentration 
tested (100 µg/ml, P = 0.0081) [Table 1]. However, genistein was 
toxic to the cells at all of the concentrations examined except for 
the lowest concentration of 16.9 µg/ml (P = 0.985) [Table 1].
Active CL
P. major (−0.10 ± 0.11), aucubin (0.06 ± 0.16), baicalein 
(−0.10 ± 0.11), and genistein (−0.18 ± 0.07) all significantly (all 
with P < 0.0001) inhibited ROS production from the neutrophils 
[Figure 1].
HPLC for P. major extract
The data were analyzed with Turbochrom software from 
Perkin‑Elmer. Standards of the components of the materials tested 
were run on the HPLC at known concentrations. Linear calibra‑
tion curves were used to calculate the concentrations of aucubin 
and baicalein based on the area of the chromatographic peaks at 
the corresponding retention times. Detection limits for each are 
defined as 5 times the signal to noise ratio. P. major extract (30×) 
contained 0.05 µg/ml of aucubin and 0.0425 µg/ml of baicalein.
DISCUSSION
Neutrophils play a key role in the host response 
against invading pathogenic microorganisms in periodontal disease 
and other oral conditions. They represent the frontline of defense 
in acute infections. A major mechanism is through phagocytosis 
and killing of the microorganism either through oxidative or 
Table 1. Cytotoxicity of plantago major, aucubin, baicalein, and 
genistein
Mean±Std. Dev P value
Plantago major, %
0.011 −8.41±0.09 0.98
0.023 −10.07±0.08 0.99
0.046 −7.93±0.11 0.97
0.187 −7.79±0.12 0.97
0.375 −7.08±0.14 0.96
0.75 −6.51±0.15 0.94
1.5 −6.68±0.13 0.95
3 −2.02±0.04 0.68
Aucubin, µg/ml
0.78 −9.79±0.10 0.99
1.5 −9.07±0.11 0.98
3.15 −8.59±0.13 0.98
6.25 −8.58±0.13 0.98
12.5 −8.87±0.13 0.98
25 −8.45±0.14 0.98
50 −8.62±0.13 0.98
100 11.49±0.17 0.0081*
Baicalein, µg/ml
0.25 −0.59±0.01 0.75
0.5 −0.79±0.01 0.82
1 −0.91±0.00 0.85
2 −0.64±0.01 0.78
Genistein, µg/ml
16.89 −4.15±0.09 0.985
33.78 14.22±0.06* 0.0001*
67.56 45.99±0.09* 0.0001*
108.09 53.53±0.08* 0.0001*
*Significant at P<0.05 compared to untreated cells
Figure 1. Chemiluminescence results showing the effects of Plantago 
major, aucubin, baicalein, and genistein on ROS production from the 
neutrophils
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non‑oxidative mechanisms. However, although their major effects 
are protective, neutrophils release toxic products that are thought to 
be partly responsible for the associated tissue destruction, such as 
ROS.[9] Some investigators had thus described the relationship of 
neutrophils and the tissue destruction as a proverbial double‑edged 
sword. There is cumulative evidence now to implicate ROS in the 
pathogenesis of several diseases including AIDS, cancer, athero‑
sclerosis, chronic inflammatory conditions such as periodontal 
and oral diseases, and in the aging process.[11,12]
For this reason, there is a growing interest in natural anti‑
oxidants found in herbs and medicinal plants that may act as 
scavengers by reducing the action of ROS and free radicals to 
support their use in the treatment of chronic inflammatory dis‑
eases. The present study investigated the effects of P. major and 
two of its main components, baicalein and aucubin, on the human 
neutrophils’ respiratory burst activity and ROS production in vitro. 
A standard CL method was used to measure the generation of ROS 
by human neutrophils. This technique was chosen because of its 
accuracy, high sensitivity, and simplicity.
Baicalein and aucubin are believed to be among the most 
important chemicals found in P. major. Baicalein, a flavonoid, 
and aucubin, an irioid glycoside, are considered the most biologi‑
cally active components of the plant.[1] Baicalein is known for its 
potential antioxidant properties and as a free radical scavenger. It 
is also known for its anti‑inflammatory activities, specifically its 
ability to inhibit inflammatory cytokines in human mast cells.[3,4] 
Aucubin is the major irioid glycoside isolated from the leaves 
and has been determined to be a specific inhibitor of nuclear 
factor‑kappa B (NF‑kB) activation in mast cells, which explains 
its anti‑inflammatory properties. Aucubin has also been shown to 
have anticancer properties, since it enhances human lymphocyte 
proliferation and the secretion of interferon g.[9] The concentra‑
tions of aucubin and baicalein selected for the CL assays were 
below the toxic levels as determined in the LDH assays. Aucubin 
at 0.01 µg/ml and baicalein at 0.085 µg/ml were chosen based on 
the LDH assays and the literature.[13‑15] The data from the HPLC 
experiment detected 0.05 µg/ml of aucubin and 0.0425 µg/ml of 
baicalein in the P. major 30× extract. Therefore, the concentrations 
of aucubin and baicalein used in the CL assays were close to the 
concentrations detected in P. major. However, these concentra‑
tions of aucubin and baicalein, as well as the P. major, inhibited 
ROS production almost completely, so future studies examining 
dose responses of these agents are needed to determine if the 
crude P. major extract works better than the individual compo‑
nents (aucubin or baicalein) in inhibiting ROS production.
Genistein was used as a control. Genistein is the major natural 
phytoestrogen polyphenolic nonsteroidal isoflavonoid found in 
soybeans.[15,16] Genistein serves as a control for inhibition due 
to its antioxidant and anti‑inflammatory properties through its 
down regulation of cytokine‑induced signal transduction events 
in the cells of the immune system.[16,17] Genistein suppresses the 
NF‑kB activation induced by ROS and subsequently inhibits the 
transcription of a variety of inflammatory genes.[16]
Non‑toxic levels of P. major, baicalein, aucubin, and genis‑
tein significantly inhibited the ROS production from the acti‑
vated neutrophils. This indicates the potential antioxidant and 
anti‑inflammatory effect of P. major and the agents. These results 
are supported by the findings of studies and reports on the wound 
healing activity of P. major.[18‑20] A clinical trial has also determined 
P. major to be effective for the treatment of chronic bronchitis.[21]
Chiang et al.,[22] studied the cytotoxic, antiviral, and immu‑
nomodulatory effects of P. major on various human leukemia, 
lymphoma, and carcinoma cells and concluded that extracts of 
P. major possess a broad spectrum of antiviral activities, as well 
as the activities that modulate cell‑mediated immunity.[22] Stef 
et al.,[23] analyzed the total antioxidant and scavenging capacity of 
P. major, among many other herbal medicines, and concluded that 
it should be considered as an antioxidant compound, as it presented 
both reducing power and radical scavenging capacity.[23] Similarly, 
Kumarasamy et al.,[24] reported that the P. major seed extracts ex‑
hibited significant free radical scavenging activity. They concluded 
that these natural antioxidant compounds from plant extracts may 
help to develop new drug candidates for antioxidant therapy.
Since there is currently sufficient evidence to implicate the 
contribution of ROS in the pathogenesis of a many diseases 
including periodontal and oral infections, and since neutrophils 
are recognized as a primary source for ROS, agents that suppress 
ROS production from neutrophils present promising therapeutic 
approaches for these diseases. Oxidative stress occurs when the 
production of ROS exceeds the body’s natural antioxidant defense 
mechanisms, causing damage to biomolecules such as lipids, pro‑
teins, and DNA. This oxidative stress is responsible for a major 
part of the general drop in cellular functions associated with many 
human diseases.
In conclusion, the results of the present study showed that the 
P. major, baicalein, and aucubin inhibited ROS production by 
human neutrophils. This makes them promising candidates for 
future extensive studies to provide evidence for their therapeutic 
potential and prove their benefits in the prevention and treatment 
of periodontal and oral conditions.
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